RAPT Therapeutics, Inc. Income (Loss) from Continuing Operations, Per Basic Share
RAPT Therapeutics, Inc. reported Income (Loss) from Continuing Operations, Per Basic Share of -$0.65 per share for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2025-11-06
- RAPT Therapeutics, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2025-09-30 was -$0.65.
- RAPT Therapeutics, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2025-06-30 was -$0.65.
- RAPT Therapeutics, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2025-03-31 was -$0.08.
- RAPT Therapeutics, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2024-09-30 was -$3.79.
- RAPT Therapeutics, Inc. income (loss) from continuing operations, per basic share for fiscal 2024 was -$3.19.
- RAPT Therapeutics, Inc. income (loss) from continuing operations, per basic share for fiscal 2023 was -$3.05.
- RAPT Therapeutics, Inc. income (loss) from continuing operations, per basic share for fiscal 2022 was -$2.58.
- RAPT Therapeutics, Inc. income (loss) from continuing operations, per basic share for fiscal 2021 was -$2.53.
| Period end | Income (Loss) from Continuing Operations, Per Basic Share 3 month | Income (Loss) from Continuing Operations, Per Basic Share 3 month as first filed | Income (Loss) from Continuing Operations, Per Basic Share 6 month | Income (Loss) from Continuing Operations, Per Basic Share 6 month as first filed | Income (Loss) from Continuing Operations, Per Basic Share 9 month | Income (Loss) from Continuing Operations, Per Basic Share 9 month as first filed | Income (Loss) from Continuing Operations, Per Basic Share 12 month |
|---|---|---|---|---|---|---|---|
| 2025-09-30 | -$0.65 10-Q · filed 2025-11-06 | -$1.94 10-Q · filed 2025-11-06 | |||||
| 2025-06-30 | -$0.65 10-Q · filed 2025-08-07 | -$1.29 10-Q · filed 2025-08-07 | |||||
| 2025-03-31 | -$0.08 10-Q · filed 2025-05-08 | ||||||
| 2024-12-31 | -$3.19 10-K · filed 2025-03-06 | ||||||
| 2024-09-30 | -$3.79 10-Q · filed 2025-11-06 | -$0.47 10-Q · filed 2024-11-12 | -$15.80 10-Q · filed 2025-11-06 | -$1.97 10-Q · filed 2024-11-12 | |||
| 2024-06-30 | -$5.69 10-Q · filed 2025-08-07 | -$0.71 10-Q · filed 2024-08-08 | -$12.01 10-Q · filed 2025-08-07 | -$1.50 10-Q · filed 2024-08-08 | |||
| 2024-03-31 | -$0.79 10-Q · filed 2025-05-08 | ||||||
| 2023-12-31 | -$3.05 10-K · filed 2025-03-06 | ||||||
| 2023-09-30 | -$0.82 10-Q · filed 2024-11-12 | -$2.24 10-Q · filed 2024-11-12 | |||||
| 2023-06-30 | -$0.66 10-Q · filed 2024-08-08 | -$1.42 10-Q · filed 2024-08-08 | |||||
| 2023-03-31 | -$0.76 10-Q · filed 2024-05-09 | ||||||
| 2022-12-31 | -$2.58 10-K · filed 2024-03-07 | ||||||
| 2022-09-30 | -$0.63 10-Q · filed 2023-11-13 | -$1.93 10-Q · filed 2023-11-13 | |||||
| 2022-06-30 | -$0.62 10-Q · filed 2023-08-11 | -$1.31 10-Q · filed 2023-08-11 | |||||
| 2022-03-31 | -$0.69 10-Q · filed 2023-05-11 | ||||||
| 2021-12-31 | -$2.53 10-K · filed 2023-03-14 | ||||||
| 2021-09-30 | -$0.63 10-Q · filed 2022-11-10 | -$1.92 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | -$0.63 10-Q · filed 2022-08-11 | -$1.29 10-Q · filed 2022-08-11 |